ENTERING INTO TECHNOLOGY TRANSFER FROM THE PROCESS SUPPLIER : GIVE AWAYS FROM EXPERIENCE · 2013....
24
ENTERING INTO TECHNOLOGY TRANSFER FROM THE PROCESS SUPPLIER : GIVE AWAYS FROM EXPERIENCE Pierre-Francois FALCOU, MD, ExMBA Alliances Director, LFB Biomedicaments, France PPB May 2013, Lanzarote, Spain
Transcript of ENTERING INTO TECHNOLOGY TRANSFER FROM THE PROCESS SUPPLIER : GIVE AWAYS FROM EXPERIENCE · 2013....
ENTERING INTO TECHNOLOGY TRANSFER FROM THE PROCESS SUPPLIER : GIVE AWAYS FROM EXPERIENCE
Pierre-Francois FALCOU, MD, ExMBAAlliances Director, LFB Biomedicaments, France
PPB May 2013, Lanzarote, Spain
DISCLAIMER
this presentation is the sole expression of the personal opinion of the speaker who takes full responsibility for the information presented by himself. It does not commit the organizers or LFB to any undertaking related to the text,
ideas or opinion expressed hereby. The author acknowledges that he has got the relevant background and experience to address the topic. Any reaction or comment
could be directed at his attention using the [email protected] email address
TECH TRANSFER SEEN FROM A PROCESS PROVIDER
Why should we do that ?
When size mattersWhen competition is concentratingWhen know-how becomes an assetWhen there is limited plasma resourcesWhen you are not expected to be the
next worldwide leader
Who are the applicant licensees ?
Countries who :
Are seeing improvement in the standard of care for a growing population
Are spending increasing money on blood productimportation
Are throwing safe plasma away Are willing to promote domestic high-tech Are building a national regulatory environment not fully
Western style
NEW TENTATIVE INCOMING COUNTRIES IN FRACTIONATION
What is the scope of the deal ?
Must of time, a turnkey fully fledged facilitybut it could stop at :
The beginningBD, rarely DDCentral plasma warehouseReal estate + equipmentUpstream fractionationAny further step before completion
What is the scope of the deal ?
Must of time, a turnkey fully fledged facilitybut it could stop at :
Plasma Products Inc.
Who are the key stakeholders ? (1/2)
The licensee, carrying the financialcredential versus
The operating companyThe sources of financingThe engineering companyThe process providerThe real estate suppliers
Who are the key stakeholders ? (1/2)
The licensee, carrying the financialcredential versusThe operating companyThe sources of financingThe engineering companyThe process providerThe real estate suppliers
Who are the key stakeholders ? (1/2)
The licensee, carrying the financialcredential versusThe operating companyThe sources of financingThe engineering companyThe process providerThe real estate suppliers
Who are the key stakeholders ? (1/2)
The licensee, carrying the financialcredential versusThe operating companyThe sources of financingThe engineering companyThe process providerThe real estate suppliers
Who are the key stakeholders ? (1/2)
The licensee, carrying the financialcredential versusThe operating companyThe sources of financingThe engineering companyThe process providerThe real estate suppliers
Who are the key stakeholders ? (2/2)
The equipment suppliersThe plasma providerThe regulatorThe customersThe WTO
Who are the key stakeholders ? (2/2)
The equipment suppliersThe plasma providerThe regulatorThe customersThe WTO
Who are the key stakeholders ? (2/2)
The equipment suppliersThe plasma providerThe regulatorThe customersThe WTO
Who are the key stakeholders ? (2/2)
The equipment suppliersThe plasma providerThe regulatorThe customersThe WTO
Who are the key stakeholders ? (2/2)
The equipment suppliersThe plasma providerThe regulatorThe customersThe WTOAnd relatedstructures
Who are the key stakeholders ? (2/2)
The equipment suppliersThe plasma providerThe regulatorThe customersThe WTOGOD … ?
FROM CONCEPTUAL TO DETAILED DESIGN
TROPICALISATION !
THE KEY WORD
INTERCULTURAL MANAGEMENT
Learning how to
SECURE YOUR PAYMENTS
ALLOW LOCAL PLAYERS TO MANAGE LOCAL TENDERS
GET THE RIGHT SIGNATURE FROM THE RIGHT GUY AT THE RIGHT TIME
WHAT YOU SHALL KEEP AS CRITICAL
TRAINING
CRITICAL PROCESS SKIDS
ANALYTICAL CONTROLS
PHARMACEUTICAL VALIDATION
CONCLUSIONS
BE PATIENT
ENFORCE A COMPREHENSIVE LEGAL FRAMEWORK
TROPICALIZE
DAILY WONDER WHAT’S THE NEXT MINUTE PROBLEM
THANK YOU !
